Can You Microdose GLP-1? How Compounded Products Differ

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This PlexusDx Education Hub guide explains microdosing and compounded GLP-1 formulations without the marketing gloss. Browse all Peptides & GLP-1 education.

"Microdose GLP-1" is a phrase that lives entirely in the world of compounding. It refers to formulations of the active ingredient produced by licensed 503A compounding pharmacies at doses below standard titration schedules, distinct from FDA-approved brand products. To understand whether microdosing is possible, you first have to understand what a compounding pharmacy can and cannot legally do.

What a 503A compounding pharmacy can legally do

503A pharmacies are state-licensed compounders that prepare patient-specific prescriptions under a valid prescriber order. Federal law permits them to compound in three broad situations: products not commercially available, products on the FDA drug shortage list, and patient-specific formulations, such as a different strength, combination, or vehicle, that are medically necessary for an individual. State pharmacy boards and the FDA maintain oversight.

What the shortage resolutions changed

The FDA declared semaglutide in shortage in 2022 and tirzepatide in shortage in 2022. During those declarations, 503A pharmacies could compound these molecules under the shortage pathway. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, which narrowed but did not close the legitimate compounding window.

What remains available

Compounded semaglutide and tirzepatide can still be prepared through the first and third pathways, meaning patient-specific variations and combinations that are not commercially available, where clinically justified. That is the legal space microdose formulations occupy.

How compounded products differ from brand products

Compounded products are legally and factually different from FDA-approved brand products. They are not subject to the same FDA manufacturing review, follow their own pharmacy-specific quality processes, and may contain different vehicles, strengths, or combinations. Quality varies by pharmacy, so verify state licensure and, where possible, third-party testing. Compounded products are not "generics" in any regulatory sense.

Where microdose and combination formulations fit

Microdose formulations deliver lower doses than standard titration schedules, sometimes aimed at patients who experience significant GI side effects at label-directed doses. Combination formulations, such as semaglutide paired with cyanocobalamin (vitamin B12), are also common; the B12 can reduce injection-site irritation for some patients and may support energy and neurological health in those who are B12-deficient. Specific strength combinations are patient-specific per the prescriber order. PlexusDx offers a Microdose GLP-1 Protocol among its Weight Management Protocols.

Safety considerations

Confirm the compounding pharmacy is licensed in your state and that the prescriber conducts a clinical evaluation reviewing contraindications. Be wary of vendors that ship without prescriptions, accept only cryptocurrency, or market "research chemical" products. Compounded products should carry patient-specific labeling, lot numbers, beyond-use dates, and storage instructions per USP standards for nonsterile or sterile preparations.

The genetics behind GLP-1 response

Whether a formulation is standard or microdosed, your genes help shape the pathways it acts on. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including pathway-level variants in FTO and MC4R, and TCF7L2 that shape baseline GLP-1 signaling and energy balance. It describes traits, not a prediction of response to any specific compound or formulation.

What "patient-specific" really means

The phrase patient-specific sits at the center of legitimate compounding, and it is worth understanding rather than glossing over. It means a formulation prepared for one individual under a valid prescriber order, based on a clinical reason that applies to that person, not a mass-market product dressed up in different packaging. A microdose or a combination formulation is legitimate precisely because a prescriber has judged it appropriate for a specific patient.

That framing also explains why quality can vary so much between pharmacies. Without the standardized FDA manufacturing review that governs brand products, the pharmacy's own processes carry more weight, which is why verifying state licensure matters.

Questions to bring to a provider

If you are curious about a compounded or microdosed formulation, the productive move is to ask a licensed provider whether it fits your situation and why. That conversation, grounded in your clinical picture, is what turns a marketing term into an informed, individual decision.

Frequently Asked Questions

Can you actually microdose GLP-1?

Microdose GLP-1 refers to compounded formulations dosed below standard titration schedules, prepared by a licensed 503A pharmacy under a valid prescriber order. Whether it is appropriate is a clinical decision your provider makes. It is a patient-specific formulation choice, not something to self-direct, and quality depends on the pharmacy preparing it.

Is a microdosed compound the same as the brand?

No. Compounded products are not subject to the same FDA manufacturing review as brand products and may differ in strength, vehicle, combinations, and quality controls. They are not "generics." Quality varies by pharmacy, so confirm state licensure and, where available, third-party testing before proceeding with any compounded formulation.

Why do some compounded formulations include B12?

Cyanocobalamin (vitamin B12) is sometimes included because it can reduce injection-site discomfort for some patients and may support those who are B12-deficient. It is a patient-specific formulation choice made by the prescribing provider, not a universal addition, and it is prepared under the individual prescriber order.

Does the genetic test predict my response to a microdose?

No. The Precision Peptide Genetic Test does not predict response to compounded semaglutide, tirzepatide, or any specific formulation. It analyzes pathway-level variants in FTO and MC4R, and TCF7L2 that shape baseline GLP-1 and energy-balance biology, offering upstream context that applies across every GLP-1 protocol.

Continue with the PlexusDx Education Hub.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.